Tuesday 23rd April 2024
RAIRDA Survey
Have your say on the way your services are working for your Rare Autoimmune Rheumatic Disease (RAIRD)
Despite the similarity of initial symptoms in primary Raynaud’s phenomenon (PRP) and secondary Raynaud’s phenomenon (SRP), the long-term implications of SRP mean that it is critical for there to be more effective assessments that can accurately specify which of the two a person may have.
and secondary Raynaud's phenomenon the long-term implications of SRP mean that it is critical for there to be more effective assessments that can accurately specify which of the two a person may have.
underlying cause), whereas SRP is associated with a range of several connective tissue diseases especially systemic sclerosis 90% of SSc patients first present with Raynaud's, and this may precede diagnosis of SSc for many years.
If a person has SRP, it is likely that the ANA blood test comes back positive. A positive ANA blood test result suggests that the patient has, or is at risk of developing, an auto-immune condition. This category includes: diabetes 1), hypothyroidism, hyperthyroidism, lupus, and SSc. If there is a positive result, a rheumatologist may decide to carry out morphological tests, such as nailfold videocapillaroscopy and functional tests tools and thermography) for further investigation. This is dependent on the hospital's resources, as these tools are still considered to be innovations' and their utilisation is not widespread across the UK as of yet.
in the Assessment of Primary and Secondary Raynaud's Phenomenon', aimed to review the above techniques to evaluate their ability to make a correct diagnosis, Raynaud's over a period of time, and investigate blood perfusion. perfusion' refers to the delivery of oxygenated blood from the arteries to the capillary bed in tissues, which allows cells to survive and grow.
evaluates blood flow at a single location, providing an indication of blood perfusion. Laser Doppler Imaging may be more effective, as it can assess more than one area and can be used to evaluate the microcirculatory blood flow. It can also aid in the differentiation of PRP and SRP within the context of scleroderma.
Tuesday 23rd April 2024
Have your say on the way your services are working for your Rare Autoimmune Rheumatic Disease (RAIRD)
Tuesday 19th March 2024
The Scleroderma and Raynaud’s UK sponsored 'Science in Medicine School Teams Prize 2024' contest is now open for entries. The contest aims to engage sixth form school students with science in medicine, and challenges students to prepare an ePoster with a novel vision on how to promote the health and well-being of individuals with Scleroderma and/or Raynaud’s. If you're interested in entering, or know someone in sixth form who might be, read on to find out more!
Wednesday 28th February 2024
As high bills continue to threaten the health of those living with the debilitating condition; SRUK is appealing to energy companies to provide financial assistance to them.